Eaton Vance fund managers see major upside for healthcare stocks -Barron’s
The portfolio managers of the $1.2 billion Eaton Vance Worldwide Health Sciences fund are expecting big gains from a trio of healthcare stocks. Jason Kritzer and Samantha Pandolfi, co-managers of the fund, highlighted Vertex Pharmaceuticals, Zoetis and Shire for future outperformance in an article in Barron's. Pandolfi says she sees 15 percent upside for drugmaker Zoetis and 40 percent upside for Dublin-based drugmaker Shire.
